Insulin-Use Safety Recommendations

This project was sponsored by Sanofi.

Webinar: Ten Ways to Prevent Insulin-Use Errors in Your Hospital
This 2014 webinar engaged an interprofessional panel of experts in a discussion about safe use of insulin in hospitals related to the Insulin-Use Safety Recommendations that were published last year in the American Journal of Health-System Pharmacy. The experts will be taking questions from the field about adopting the recommendations as well.

The Experts
• Patricia C. Kienle, R.Ph., M.P.A., FASHP, Director, Accreditation and Medication Safety, Cardinal Health Innovative Delivery Solutions
• Gregory Maynard, M.D., M.Sc., Health Sciences Professory of Medicine, UCSD Division of Hospital Medicine
• Kristen Kulasa, M.D., Assistant Clinical Professor of Medicine, Director, Inpatient Glycemic Control, Division of Endocrinology, Diabetes, and Metabolism, University of California, San Diego
• Robert Weber, Pharm.D., M.S., BCPS, FASHP, Administrator, Pharmaceutical Services, Ohio State University Medical Center.

Prior to viewing the webinar, we encourage you to familiarize yourself with the recommendations and to listen to a recording of the Midyear session on the same topic.

Download a PDF of the webinar slides here.

The Institute for Safe Medication Practices identifies insulin as an inpatient high-alert medication. Insulin
is frequently cited as one of the medications commonly implicated in medication errors in hospitals, and
insulin-related medication errors have the potential to result in serious harm, including death. For
example, “Insulin, Hospitals and Harm: A Review of Patient Safety Incidents Reported to the National
Patient Safety Agency” stated that in a review of 16,600 patient safety incidents involving insulin, 24
percent resulted in patient harm. “A Systems Approach to Reducing Errors in Insulin Therapy in the
Inpatient Setting,” which appeared in Endocrine Practice, reported that insulin was implicated in 33
percent of medication error-related deaths.

These recommendations have been endorsed by the American Academy of Pediatrics, the American
Association of Clinical Endocrinologists, the American Association of Nurse Anesthetists and The
Endocrine Society. They are supported by the American College of Clinical Toxicology, the American
College of Emergency Physicians, ISMP and the Society of Hospital Medicine.

Read the complete article about the insulin-use safety recommendations, “Enhancing Insulin-Use
Safety in Hospitals: Practical Recommendations From an ASHP Foundation Expert Consensus Panel,”
now. [This article has been posted with permission from AJHP.]